Literature DB >> 1316286

Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data.

A E Ades1.   

Abstract

Accurate incidence information is required to plan and evaluate screening programmes which have been proposed for the detection of primary toxoplasmosis and cytomegalovirus infection in pregnancy. Appropriate statistical methods are described for deriving incidence rates and their confidence intervals from three types of data: change in age-specific seroprevalence, seroconversion, and IgM studies. These methods are applied to seven published studies on toxoplasmosis and cytomegalovirus carried out in the UK. In these publications only one estimate of the infection rate per pregnancy was correctly derived, and none were accompanied by confidence intervals. Using the proposed methods, most estimates of the primary toxoplasmosis rate in these studies were between 2.5 and 5.5 per 1000 pregnancies, compared to the 2 per 1000 usually cited. Most cytomegalovirus incidence estimates were between 4 and 10 per 1000 pregnancies.

Entities:  

Mesh:

Year:  1992        PMID: 1316286      PMCID: PMC2271994          DOI: 10.1017/s0950268800049839

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  20 in total

1.  Evaluating the sensitivity and predictive value of tests of recent infection: toxoplasmosis in pregnancy.

Authors:  A E Ades
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

2.  Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection.

Authors:  A E Ades; C S Peckham; G E Dale; J M Best; S Jeansson
Journal:  J Epidemiol Community Health       Date:  1989-03       Impact factor: 3.710

3.  Binomial regression in GLIM: estimating risk ratios and risk differences.

Authors:  S Wacholder
Journal:  Am J Epidemiol       Date:  1986-01       Impact factor: 4.897

4.  Toxoplasmosis in pregnancy.

Authors:  C F Ruoss; G L Bourne
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-12

5.  Screening for toxoplasma in pregnancy.

Authors:  D H Joynson; R Payne
Journal:  Lancet       Date:  1988-10-01       Impact factor: 79.321

6.  A prospective study of cytomegalovirus infection in pregnancy. I. Laboratory evidence of congenital infection following maternal primary and reactivated infection.

Authors:  S Grant; E Edmond; J Syme
Journal:  J Infect       Date:  1981-03       Impact factor: 6.072

7.  The estimation of age-related rates of infection from case notifications and serological data.

Authors:  B T Grenfell; R M Anderson
Journal:  J Hyg (Lond)       Date:  1985-10

8.  A prospective study of primary cytomegalovirus infection during pregnancy: final report.

Authors:  P D Griffiths; C Baboonian
Journal:  Br J Obstet Gynaecol       Date:  1984-04

9.  Congenital cytomegalovirus infection.

Authors:  P M Preece; K N Pearl; C S Peckham
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

Review 10.  Toxoplasmosis in humans: discussion paper.

Authors:  D O Ho-Yen
Journal:  J R Soc Med       Date:  1990-09       Impact factor: 18.000

View more
  10 in total

1.  Prevalence of toxoplasma IgG among pregnant women in west London according to country of birth and ethnic group.

Authors:  R E Gilbert; P A Tookey; W D Cubitt; A E Ades; J Masters; C S Peckham
Journal:  BMJ       Date:  1993-01-16

2.  Screening for toxoplasmosis during pregnancy.

Authors:  C S Peckham; S Logan
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

3.  Maternal prevalence of Toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis.

Authors:  A E Ades; S Parker; R Gilbert; P A Tookey; T Berry; M Hjelm; A H Wilcox; D Cubitt; C S Peckham
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

4.  Detection of Toxoplasma gondii tachyzoites and bradyzoites in blood, urine, and brains of infected mice.

Authors:  T D Nguyen; M de Kesel; G Bigaignon; P Hoet; G Pazzaglia; M Lammens; M Delmee
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

5.  Risk factors for recent toxoplasma infection in pregnant women in Naples.

Authors:  W Buffolano; R E Gilbert; F J Holland; D Fratta; F Palumbo; A E Ades
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

6.  Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth.

Authors:  R E Gilbert; M R Stanford; H Jackson; R E Holliman; M D Sanders
Journal:  BMJ       Date:  1995-04-22

7.  Seroepidemiology of Toxoplasma gondii among pregnant women in different parts of Sweden.

Authors:  I Ljungström; E Gille; J Nokes; E Linder; M Forsgren
Journal:  Eur J Epidemiol       Date:  1995-04       Impact factor: 8.082

8.  Prenatal diagnosis and prevention of toxoplasmosis in pregnant women in Northern Vietnam: study protocol.

Authors:  G Suzanne A Smit; Thi Lam Binh Vu; Trung Dung Do; Niko Speybroeck; Brecht Devleesschauwer; Elizaveta Padalko; Ellen Roets; Pierre Dorny
Journal:  BMC Infect Dis       Date:  2017-05-25       Impact factor: 3.090

9.  Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation.

Authors:  F Nogareda; Y Le Strat; I Villena; H De Valk; V Goulet
Journal:  Epidemiol Infect       Date:  2013-11-14       Impact factor: 4.434

10.  Incidence of cytomegalovirus infection among the general population and pregnant women in the United States.

Authors:  Fernando A B Colugnati; Stephanie A S Staras; Sheila C Dollard; Michael J Cannon
Journal:  BMC Infect Dis       Date:  2007-07-02       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.